Circadian rhythm, oxidative stress, and cancer immunosuppression
Archives of Toxicology · 2026
DOI: 10.1007/s00204-026-04500-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Toxicology, 2026. Verfasst von Li You und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Physical Education and Health, Chongqing College of International Business and Economics, Chongqing, 401520, China. Hauptthemen laut MEDLINE: Oxidative Stress, Circadian Rhythm, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 150 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hubei Province Regional Science and Technology Innovation Plan Project, Excellence FIM UHK.
Abstract (Originalsprache)
Circadian rhythm and oxidative stress are fundamental biological regulators whose intricate interplay plays a pivotal role in cancer progression and immunosuppression. These two factors engage in a bidirectional, self-reinforcing pathological loop that drives tumor progression and fosters an immunosuppressive tumor microenvironment. In the context of cancer, circadian rhythm disruption promotes immunosuppression by reducing cytotoxic CD8+ T cell infiltration while expanding populations of immunosuppressive cells such as regulatory T cells and myeloid-derived suppressor cells. Oxidative stress acts as a pivotal effector with dual roles, it promotes immunosuppression by polarizing macrophages toward an M2 phenotype, yet it is also strategically harnessed to disrupt immunosuppressive networks. Critically, oxidative stress serves as a central link, wherein circadian rhythm disruption, through the accumulation of ROS, drives the recruitment of immunosuppressive cells and upregulates immune checkpoints such as PD-L1, thereby suppressing anti-tumor immunity. Furthermore, emerging evidence highlights the potential of circadian rhythm as a prognostic biomarker and underscores the promise of chrono-immunotherapy, which strategically times interventions to align with the circadian rhythm to optimize anti-tumor immune function. Collectively, the circadian rhythm and redox balance represent novel therapeutic targets, with pharmacological agents that restore circadian rhythm and enable cell-selective modulation of oxidative stress. Thus, integrating circadian rhythm and oxidative stress into oncology offers a promising strategy to improve cancer prevention, prognosis, and treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Physical Education and Health, Chongqing College of International Business and Economics, Chongqing, 401520, China.
- College of Life Science, Yangtze University, Jingzhou, 434025, China.
- Department of Chemistry, Faculty of Science, University of Hradec Králové, 500 03, Hradec Králové, Czech Republic.
- College of Life Science, Yangtze University, Jingzhou, 434025, China. wqh212@hotmail.com.
- Centre for Basic and Applied Research, Faculty of Informatics and Management, University of Hradec Kralove, 500 03, Hradec Králové, Czech Republic. kamil.kuca@uhk.cz.
ORCID-Profile: Kamil Kuca
Förderung
- National Natural Science Foundation of China
- Hubei Province Regional Science and Technology Innovation Plan Project
- Excellence FIM UHK
- UHK
Zitieren
APA
You, L., Nepovimova, E., Wu, Q., & Kuca, K. (2026). Circadian rhythm, oxidative stress, and cancer immunosuppression. Archives of Toxicology. https://doi.org/10.1007/s00204-026-04500-1
Vancouver
You L, Nepovimova E, Wu Q, Kuca K. Circadian rhythm, oxidative stress, and cancer immunosuppression. Archives of Toxicology. 2026. doi:10.1007/s00204-026-04500-1
BibTeX
@article{You2026,
author = {You, Li and Nepovimova, Eugenie and Wu, Qinghua and Kuca, Kamil},
title = {Circadian rhythm, oxidative stress, and cancer immunosuppression},
journal = {Archives of Toxicology},
year = {2026},
doi = {10.1007/s00204-026-04500-1}
}
EUVIMED